U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H36N6O6
Molecular Weight 528.6006
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of ZED-1227

SMILES

CCC(CC)CNC(=O)CN1C=CC=C(NC(=O)[C@H](CC\C=C\C(=O)OC)NC(=O)C2=CN=CN2C)C1=O

InChI

InChIKey=VHGWUSABWIEXKQ-BEBFYNPSSA-N
InChI=1S/C26H36N6O6/c1-5-18(6-2)14-28-22(33)16-32-13-9-11-20(26(32)37)30-24(35)19(10-7-8-12-23(34)38-4)29-25(36)21-15-27-17-31(21)3/h8-9,11-13,15,17-19H,5-7,10,14,16H2,1-4H3,(H,28,33)(H,29,36)(H,30,35)/b12-8+/t19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C26H36N6O6
Molecular Weight 528.6006
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 1
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:55:07 GMT 2023
Edited
by admin
on Sat Dec 16 11:55:07 GMT 2023
Record UNII
T4SR539YKF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZED-1227
Code English
TAK-227
Code English
2-Heptenoic acid, 7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1H-imidazol-5-yl)carbonyl]amino]-7-oxo-, methyl ester, (2E,6S)-
Systematic Name English
ZED1227
Code English
(2E,6S)-7-((1-(2-((2-ETHYLBUTYL)AMINO)-2-OXOETHYL)-1,2-DIHYDRO-2-OXO-3-PYRIDINYL)AMINO)-6-(((1-METHYL-1H-IMIDAZOL-5-YL)CARBONYL)AMINO)-7-OXO-2-HEPTENOIC ACID METHYL ESTER
Systematic Name English
METHYL (E,6S)-7-((1-(2-(2-ETHYLBUTYLAMINO)-2-OXO-ETHYL)-2-OXO-3-PYRIDYL)AMINO)-6-((3-METHYLIMIDAZOLE-4-CARBONYL)AMINO)-7-OXO-HEPT-2-ENOATE
Systematic Name English
Methyl (2E,6S)-7-[[1-[2-[(2-ethylbutyl)amino]-2-oxoethyl]-1,2-dihydro-2-oxo-3-pyridinyl]amino]-6-[[(1-methyl-1H-imidazol-5-yl)carbonyl]amino]-7-oxo-2-heptenoate
Systematic Name English
Code System Code Type Description
FDA UNII
T4SR539YKF
Created by admin on Sat Dec 16 11:55:07 GMT 2023 , Edited by admin on Sat Dec 16 11:55:07 GMT 2023
PRIMARY
SMS_ID
300000042592
Created by admin on Sat Dec 16 11:55:07 GMT 2023 , Edited by admin on Sat Dec 16 11:55:07 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
ZED-1227
Created by admin on Sat Dec 16 11:55:07 GMT 2023 , Edited by admin on Sat Dec 16 11:55:07 GMT 2023
PRIMARY
PUBCHEM
72950407
Created by admin on Sat Dec 16 11:55:07 GMT 2023 , Edited by admin on Sat Dec 16 11:55:07 GMT 2023
PRIMARY
CAS
1542132-88-6
Created by admin on Sat Dec 16 11:55:07 GMT 2023 , Edited by admin on Sat Dec 16 11:55:07 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Originator: Zedira GmbH; Developer: Dr Falk Pharma, University Medical Center of the Johannes Gutenberg University Mainz, Zedira GmbH; Class: Small molecule; Mechanism of Action: Trans-glutaminase 2 inhibitor; Orphan Drug Status: No; On Fast track: No; New Molecular Entity: Yes; Highest Development Phase: Phase I for Coeliac disease; Most Recent Event: No Data Available
ACTIVE MOIETY
Zedira, Dr. Falk Pharma and the University of Mainz Hospital, which together comprise a flagship project of the Ci3 leading-edge cluster, are to receive additional subsidy funding for clinical development of a celiac disease drug.